tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VOR Stock Latest News

Vor Biopharma’s Telitacicept: A Promising Buy Amidst Valuation Disconnect and Strategic Focus on Unmet Needs
RatingsVor Biopharma’s Telitacicept: A Promising Buy Amidst Valuation Disconnect and Strategic Focus on Unmet Needs
3d ago
VOR
Vor Biopharma Approves Stock Option Repricing Plan
PremiumCompany Announcements
Vor Biopharma Approves Stock Option Repricing Plan
3d ago
8K
VOR
Vor Bio initiated with an Overweight at JPMorgan
PremiumThe Fly
Vor Bio initiated with an Overweight at JPMorgan
3d ago
VOR
Vor Bio assumed with a Neutral at Wedbush
PremiumThe Fly
Vor Bio assumed with a Neutral at Wedbush
17d ago
VOR
Vor Biopharma Reports Q3 2025 Financial Results and Strategic Updates
PremiumCompany Announcements
Vor Biopharma Reports Q3 2025 Financial Results and Strategic Updates
24d ago
VOR
Vor Bio price target lowered to $32 from $55 at H.C. Wainwright
PremiumThe FlyVor Bio price target lowered to $32 from $55 at H.C. Wainwright
28d ago
VOR
Vor Biopharma Announces $93.7 Million Public Offering
Premium
Company Announcements
Vor Biopharma Announces $93.7 Million Public Offering
30d ago
8K
VOR
Vor Bio 10M share Spot Secondary priced at $10.00
Premium
The Fly
Vor Bio 10M share Spot Secondary priced at $10.00
1M ago
VOR
Vor Bio $100M Spot Secondary; price range $10.00-$12.00
PremiumThe Fly
Vor Bio $100M Spot Secondary; price range $10.00-$12.00
1M ago
VOR
Vor Bio announces $100M common stock offering
PremiumThe Fly
Vor Bio announces $100M common stock offering
1M ago
VOR
Vor Bio achieves primary endpoint in Stage A of Phase 3 study of telitacicept
PremiumThe Fly
Vor Bio achieves primary endpoint in Stage A of Phase 3 study of telitacicept
1M ago
VOR
Vor Biopharma Appoints New Chief Medical Officer
PremiumCompany Announcements
Vor Biopharma Appoints New Chief Medical Officer
1M ago
8K
VOR
Vor Bio appoints Sokolove as Chief Medical Officer
PremiumThe FlyVor Bio appoints Sokolove as Chief Medical Officer
1M ago
VOR
ROIV
Vor Bio says telitacicept shows sustained efficacy in China Phase 3 study
Premium
The Fly
Vor Bio says telitacicept shows sustained efficacy in China Phase 3 study
1M ago
VOR
Vor Bio price target adjusted to $55 at H.C. Wainwright after reverse split
Premium
The Fly
Vor Bio price target adjusted to $55 at H.C. Wainwright after reverse split
1M ago
VOR
Vor Biopharma Unveils Promising Phase 3 Trial Results
PremiumCompany Announcements
Vor Biopharma Unveils Promising Phase 3 Trial Results
1M ago
8K
VOR
Major Moves: Fifth Third, HEICO, Transdigm, Cytokinetics, Vor Biopharma
PremiumWeekend Updates
Major Moves: Fifth Third, HEICO, Transdigm, Cytokinetics, Vor Biopharma
2M ago
HEI
TDG
Vor Bio announces Phase 3 study on telitacicept in SLE met primary endpoint
PremiumThe Fly
Vor Bio announces Phase 3 study on telitacicept in SLE met primary endpoint
2M ago
VOR
Vor Bio upgraded to Outperform from Neutral at Baird
PremiumThe Fly
Vor Bio upgraded to Outperform from Neutral at Baird
2M ago
VOR
Vor Bio, RemeGen announce Phase 3 study of telitacicept met primary endpoint
PremiumThe FlyVor Bio, RemeGen announce Phase 3 study of telitacicept met primary endpoint
2M ago
VOR
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
BNC
VOR
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
CEP
FLY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >